Cystathionine γ-Lyase deficiency protects mice from Galactosamine/lipopolysaccharide-induced acute liver failure

Antioxidants and Redox Signaling

Volumn 20, Issue 2, 2014, Pages 204-216

  Shirozu, Kazuhiro ^a   Tokuda, Kentaro ^a   Marutani, Eizo ^a   Lefer, David ^b   Wang, Rui ^c   Ichinose, Fumito ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LAKEHEAD UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; CASPASE 3; GALACTOSAMINE; HOMOCYSTEINE; LIPOPOLYSACCHARIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROPARGYLGLYCINE; SODIUM THIOSULFATE; STRESS ACTIVATED PROTEIN KINASE; THIOSULFATE; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; URIDINE;

ACUTE LIVER FAILURE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; C57BL 6 MOUSE; CELL DEATH; CONTROLLED STUDY; CYSTATHIONINE GAMMA LYASE DEFICIENCY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME DEFICIENCY; ENZYME INDUCTION; HEPATITIS; LIVER CELL; LIVER INJURY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SURVIVAL RATE; WILD TYPE;

ANIMALS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; CYSTATHIONINE GAMMA-LYASE; DISEASE MODELS, ANIMAL; GALACTOSAMINE; GENE EXPRESSION REGULATION; HEPATOCYTES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; LIVER; LIVER FAILURE, ACUTE; MACROPHAGES, PERITONEAL; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MODELS, BIOLOGICAL; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; QUINONE REDUCTASES; SULFIDES; THIOSULFATES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891768231     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5354     Document Type: Article

References (35)

1. Ang SF, Moochhala SM, and Bhatia M. Hydrogen sulfide promotes transient receptor potential vanilloid 1-mediated neurogenic inflammation in polymicrobial sepsis. Crit Care Med 38: 619-628, 2010.
2. Behrends M, Martinez-Palli G, Niemann CU, Cohen S, Ramachandran R, and Hirose R. Acute hyperglycemia worsens hepatic ischemia/reperfusion injury in rats. J Gastrointest Surg 14: 528-535, 2010.
3. Bernas T and Dobrucki J. Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry 47: 236-242, 2002.
4. Das J, Ghosh J, Roy A, and Sil PC. Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/ nitrosative stress via Nrf2-NFkappaB pathways. Toxicol Appl Pharmacol 260: 35-47, 2012.
5. Galanos C, Freudenberg MA, and Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A 76: 5939-5943, 1979.
6. Gan N, Mi L, Sun X, Dai G, Chung FL, and Song L. Sulforaphane protects Microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response. Toxicol Appl Pharmacol 247: 129-137, 2010.
7. Hourihan JM, Kenna JG, and Hayes JD. The gasotransmitter hydrogen sulfide induces Nrf2-target genes by inactivating the Keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between Cys-226 and Cys-613. Antioxid Redox Signal 19: 465-481, 2013.
8. Hayes JD and McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 34: 176-188, 2009.
9. Jackson MR, Melideo SL, and Jorns MS. Human sulfide: quinone oxidoreductase catalyzes the first step in hydrogen sulfide metabolism and produces a sulfane sulfur metabolite. Biochemistry 51: 6804-6815, 2012.
10. Kida K, Yamada M, Tokuda K, Marutani E, Kakinohana M, Kaneki M, and Ichinose F. Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinsons disease. Antioxid Redox Signal 15: 343-352, 2011.
11. Koka S, Das A, Salloum FN, and Kukreja RC. Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice. Free Radic Biol Med 60: 80-88, 2013.
12. Latchoumycandane C, Goh CW, Ong MM, and Boelsterli UA. Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury. Hepatology 45: 412-421, 2007.
13. Lee WM. Acute liver failure. N Engl J Med 329: 1862-1872, 1993.
14. Lotarski SM, Donevan S, El-Kattan A, Osgood S, Poe J, Taylor CP, and Offord J. Anxiolytic-like activity of pregabalin in the Vogel conflict test in alpha2delta-1 (R217A) and alpha2delta-2 (R279A) mouse mutants. J Pharmacol Exp Ther 338: 615-621, 2011.
15. MacGarvey NC, Suliman HB, Bartz RR, Fu P, Withers CM, Welty-Wolf KE, and Piantadosi CA. Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis. Am J Respir Crit Care Med 185: 851-861, 2012.
16. Mani S, Yang G, and Wang R. A critical life-supporting role for cystathionine gamma-lyase in the absence of dietary cysteine supply. Free Radic Biol Med 50: 1280-1287, 2011.
17. Marutani E, Kosugi S, Tokuda K, Khatri A, Nguyen R, Atochin DN, Kida K, Van Leyen K, Arai K, and Ichinose F. A novel hydrogen sulfide-releasing N-methyl-D-Aspartate receptor antagonist prevents ischemic neuronal death. J Biol Chem 287: 32124-32135, 2012.
18. Niture SK and Jaiswal AK. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem 287: 9873-9886, 2012.
19. Paul BD and Snyder SH. H(2)S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol 13: 499-507, 2012.
20. Rahman TM and Hodgson HJ. Animal models of acute hepatic failure. Int J Exp Pathol 81: 145-157, 2000.
21. Rossi R, Giustarini D, Milzani A, and Dalle-Donne I. Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings. J Cell Mol Med 13: 3131-3140, 2009.
22. Seglen PO. Preparation of rat liver cells.3. Enzymatic requirements for tissue dispersion. Exp Cell Res 82: 391-398, 1973.
23. Shen X, Pattillo CB, Pardue S, Bir SC, Wang R, and Kevil CG. Measurement of plasma hydrogen sulfide in vivo and in vitro. Free Radic Biol Med 50: 1021-1031, 2011.
24. Shimizu S, Konishi A, Kodama T, and Tsujimoto Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci U S A 97: 3100-3105, 2000.
25. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD, Jr., and Chen LB. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-Aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A 88: 3671-3675, 1991.
26. Suzuki S, Nakamura S, Koizumi T, Sakaguchi S, Baba S, Muro H, and Fujise Y. The beneficial effect of a prostaglandin I2 analog on ischemic rat liver. Transplantation 52: 979-983, 1991.
27. Takekawa M, Tatebayashi K, and Saito H. Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. Mol Cell 18: 295-306, 2005.
28. Tokuda K, Kida K, Marutani E, Crimi E, Bougaki M, Khatri A, Kimura H, and Ichinose F. Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal 17: 11-21, 2012.
29. Tunon MJ, Alvarez M, Culebras JM, and Gonzalez-Gallego J. An overview of animal models for investigating the patho-genesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol 15: 3086-3098, 2009.
30. Wang R. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev 92: 791-896, 2012.
31. Wang X, Wang Z, Liu JZ, Hu JX, Chen HL, Li WL, and Hai CX. Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte. Toxicol In Vitro 25: 839-847, 2011.
32. Wintner EA, Deckwerth TL, Langston W, Bengtsson A, Leviten D, Hill P, Insko MA, Dumpit R, VandenEkart E, Toombs CF, and Szabo C. A monobromobimane-based assay to measure the pharmacokinetic profile of reactive sulphide species in blood. Br J Pharmacol 160: 941-957, 2010.
33. Yamada H, Akahoshi N, Kamata S, Hagiya Y, Hishiki T, Nagahata Y, Matsuura T, Takano N, Mori M, Ishizaki Y, Izumi T, Kumagai Y, Kasahara T, Suematsu M, and Ishii I. Methionine excess in diet induces acute lethal hepatitis in mice lacking cystathionine gamma-lyase, an animal model of cystathioninuria. Free Radic Biol Med 52: 1716-1726, 2012.
34. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, and Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590, 2008.
35. Zou CG, Gao SY, Zhao YS, Li SD, Cao XZ, Zhang Y, and Zhang KQ. Homocysteine enhances cell proliferation in hepatic myofibroblastic stellate cells. J Mol Med (Berl) 87: 75-84, 2009.